FREE Academic eLearning Management System for all Specialties

Learn from 58,051 multiple-choice and 21,010 flashcard questions with explanations linked to PubMed indexed review articles

Contribute to a growing collection of 2,042 PubMed Indexed Review Articles

See our list of 558 specialties



Today's Pearl is our featured PubMed indexed article written by our authors.


Sign up for free to get this daily e-mail and daily questions in your specialty!


Want to contribute and become a published author and receive lifetime access to all of our content?



Learn More


Today's Pearl is:

Lysergic Acid Diethylamide (LSD)

Lysergic acid diethylamide (LSD) is a classical hallucinogen originally synthesized by Albert Hoffman. He accidentally concocted the drug while making experimental substances from ergots to create circulatory and respiratory stimulants. The most pronounced effect on the animals allowed him to create a model for psychosis and study the induced temporary psychotic-like states. During the psychotic state, he also noted permitted recall and produced improved insight.

In 1986, almost 400 patients were treated with LSD. The Danish LSD Damages Law was passed because of the crimes and deaths linked to LSD usage where applicants received financial compensation for harm resulting from the treatments. Many years afterwards, patients still suffered from the side effects of being treated with LSD.

Regulations on hallucinogenic drugs started to be introduced in 1967 to limit the use of LSD and other hallucinogenic drugs to qualified practitioners. The hope was to eliminate or decrease the risky behaviors and resulting in harmful consequences that were brought on by the drug. Despite these efforts, LSD-assisted treatments continued in some European countries in the 1970s. In Switzerland, psychotherapy and research were also conducted from 1988 to 1993 with special permission from their government.  

No approved indications for LSD-assisted therapy exist today. It has been used in the past for non-FDA approved indications: depressive disorders including those with conversion phobia, neurosis, manic-depression and reactive depression, cyclothymic (obsessional) and passive-aggressive (obsessional) compulsive sexual deviation addiction, psychoneurotic disorders, mixed, pan-neuroticism (including schizophrenia), borderline or latent and personality disorders (especially transient situational).

Researchers continue to study the utility of LSD-assisted therapy. The following non-FDA approved indications show the most evidence for serotonin-based psychoactive agents: substance use disorders, especially in the treatment of chronic alcohol addiction, post traumatic stress disorder, anxiety, and depression in patients suffering from life-threatening illnesses. Combining LSD with counseling, researchers were able to create a psychedelic "trip" for the terminally ill, thereby decreasing the anxiety refractory to conventional anxiolytic therapy, depression, and pain associated with the life-threatening diseases such as cancer. Sleep reportedly improved with terminally ill patients, and they were less preoccupied with death.

Research has also begun to look at LSD as a possible treatment for Alzheimer dementia and as a last resort for migraines or cluster headaches. This is in part because patients have self-medicated using LSD off-label as an ablative therapy to treatment-resistant migraines and cluster headaches. Patients obtained the illicit psychoactive substances as a last resort. When patients use LSD as a treatment or a recreational drug, there are few if any reports of psychoactive effects. The effects were reported to be tolerated or avoided using minimal doses.  

LSD-assisted therapy has been found to enhance suggestibility without hypnotic induction. It has shown the most improvement in suggestibility in neurotic and schizophrenic patients but the least in depression. Neural plasticity in the cortex and cognitive flexibility are possibly required for demonstrable improvement in suggestibility.

Read Full Article and Take a Quiz

Become a contributor of StatPearls and enjoy the benefits.

Access to all of our content

Become a published author or editor

Advertising-free emails and online questions


StatPearls PubMed articles are growing daily due to contributions from many. Contribute and make a difference in your specialty!

Search our PubMed Book with articles across all of our specialties:

Create and Take Quizzes, Track Your Progress


Click on a category to see the specialties, then click your specialty to see a sample question from our extensive database:

Select a category above to show the specialties

then click on a specialty to see an example question

assignment

Join the Thousands Already Contributing!

Become a PubMed indexed published author or editor in peer-reviewed articles, eBooks, Apps, and our FREE online eLearning Management System used by students worldwide!


Author

You will receive academic credit for your work as it will be published and indexed in PubMed.

Write a brief review article summary and write 1-3 questions with explanations on the topic you select.

Article Editor

You will receive academic credit for your work as it will be published and indexed in PubMed.

Edit and sometimes help write a brief review article summary (1000 words); edit/improve/peer review questions already written on the topic; and possibly write a few new questions on the topic if needed.

Editor-in-Chief

Editors-in-Chief receive a 5% annual royalty for managing the publication of content developed within your specialty.

Manipulate the database of questions and review articles assigned to your specialty area; suggest new keyword articles that should be added; and assist in recruiting authors and editors.

We have designed the entire system to allow all contributors to make a minimal time commitment of 2-10 hours while allowing you to maximize the quality of the content for your specialty.

The goal of this project is to provide the world with a very inexpensive database of multiple choice questions and short review articles designed to assist health professionals in identifying and improving their educational weaknesses while receiving continuing medical education credits for their study time.


All contributors receive free lifetime access to the learning system as well as free unlimited CME/CE when it becomes available in your specialty area.

Start Contributing

Apps and eBooks


Prepare for your tests with our mobile apps, or download our eBook to help you study. Available and updated on all major platforms.

Google Apps

Get it on Google Play

Surgical Apple Apps

Get it on the App Store

Medical Apple Apps

Get it on the App Store